Sponsor
Royal Prince Alfred Hospital, Sydney, Australia
Clinical research sponsor
Clinical trials
11 shownQT Interval Abnormalities in Sulfonylurea Treated Type 2 Diabetes: Relationship to Treatment Induced HypoglycaemiaNCT02298803 · lead sponsor · 2015-01-01
COMPLETEDCardiotoxicity of Adjuvant TrastuzumabNCT00858039 · lead sponsor · 2009-02-01
COMPLETEDSafety of Discontinuing NSBBs in Cirrhotic Patients With Managed Primary Aetiological FactorsNCT06549673 · collaborator · 2025-01-20
RECRUITINGContinuous Glucose Monitoring for Women With Gestational DiabetesNCT06310356 · collaborator · 2024-11-18
RECRUITINGNon-selective Beta-blocker in Compensated Advanced Chronic Liver DiseaseNCT06449339 · collaborator · 2024-07-17
RECRUITINGPolysomnographic Titration of Non-invasive Ventilation in Motor Neurone DiseaseNCT05136222 · collaborator · 2021-12-15
RECRUITINGPVRI GoDeep Global Deep Phenotyping Meta-Registry for Pulmonary HypertensionNCT05329714 · collaborator · 2020-01-30
RECRUITINGThe EXCEL Registry of Patients Requiring ECMONCT03793257 · collaborator · 2019-02-01
RECRUITINGbNAbs and Anti-PD-1 in HIVNCT07820813 · collaborator · 2026-09-15
NOT_YET_RECRUITINGPolydiuretic Therapy for HFpEF, a Randomised Controlled TrialNCT05129722 · collaborator · 2022-10-01
TERMINATEDCPAP in PreeclampsiaNCT02303834 · collaborator · 2015-02-01
TERMINATEDSponsor roles
collaborator9
lead sponsor2
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.